What this trial means for you
This study is opening soon at 26 US sites. It's studying Cagrisema, Placebo CagriSema for overweight, obesity.
What participants typically get: study medication (or placebo, if the trial uses one) and study-related medical care at no cost, plus close monitoring. Compensation for time and travel varies by study — ask the site. Note that in many trials you can't choose your treatment group, and some participants receive a placebo.
The study, in the sponsor's words
This study is being done to find out how well a medicine called CagriSema helps people with overweight or obesity lose weight. CagriSema is still being tested in studies and is not yet available for doctors to prescribe. In this study the sponsor will compare two version of CagriSema injected by two different types of injection devices. Which treatment participants get is decided by chance using a computer program, so neither participants nor study staff will know which treatment is given. The study will last for about one year.
Can you join? The exact criteria
Below is the verbatim eligibility text from the registry — bring it to your doctor; it's written for clinicians, and your own clinician is the right person to interpret it with you.
Full eligibility criteria (for you and your doctor)
Inclusion Criteria: * Male or female (sex at birth) * Age 18 years or above at the time of signing the informing consent. * Body Mass Index (BMI) is greater than or equal to (\>= ) 30.0 kilograms per square metre (kg/m\^2) or BMI \>= 27.0 kg/m\^2 with the presence of at least one obesity-related complication including, but not limited to, hypertension, dyslipidaemia, obstructive sleep apnoea or cardiovascular disease. Exclusion Criteria: * Glycosylated haemoglobin (HbA1c) \>= 6.5 % (48 millimoles per mole \[mmol/mol\]) as measured by the central laboratory at screening. * History of type 1 or type 2 diabetes. * Previous exposure to CagriSema in a clinical study.
Study sites by state
Alabama
- Uni of Alabama at Birmingham — Birmingham
- Cahaba Research — Pelham
California
- Advanced Investigative Medicine, Inc. — Hawthorne
- Southern Cal Clinical Research — Santa Ana
- Encompass Clinical Research_Spring Valley — Spring Valley
Connecticut
- Chase Medical Research LLC — Waterbury
Florida
- NextPhase Research — Hollywood
- Oceane 7 Medical & Research Center, Inc. — Miami
- ForCare Clinical Research — Tampa
Georgia
- EBGS Clinical Research Center, LLC — Snellville
- Rophe Adult & Pediatric Medicine — Union City
Idaho
- Rocky Mountain Diabetes and Osteoporosis Center — Idaho Falls
Illinois
- PGM Research of Christie Clinic — Champaign
Michigan
- Arcturus HC PLC Troy Med Res — Troy
Mississippi
- Anointed Nephrology & HTN, LLC — Brookhaven
Nevada
- Palm Research Center Inc. — Las Vegas
- Palm Research Center Inc. — Las Vegas
New York
- Weill Medical College of Cornell University — New York
Oklahoma
- Alliance for Multispecialty Research — Norman
South Carolina
- Tribe Clinical Research LLC — Greenville
- Walker Family Care — Little River
Texas
- Elligo Clin Res Centre — Austin
- University of Texas Southwestern Medical Center — Dallas
- Forefront Med Res Inst PLLC — Harlingen
Virginia
- TPMG Clinical Research — Newport News
Washington
- Capital Clin Res Ctr,LLC — Olympia
View the official record on ClinicalTrials.gov →
Follow this trial
Get an email when our monthly digest covers enrollment changes and results for trials like this one.
Newsletter signup launches soon. (Site owner: set PUBLIC_BUTTONDOWN_USERNAME in
.env to activate this form.)